David E. Ball - 04 Mar 2022 Form 4 Insider Report for AVANOS MEDICAL, INC. (AVNS)

Role
SVP - Global Supply Chain
Signature
/s/ Mojirade James, as attorney-in-fact for David E. Ball
Issuer symbol
AVNS
Transactions as of
04 Mar 2022
Net transactions value
$0
Form type
4
Filing time
08 Mar 2022, 10:35:42 UTC
Previous filing
21 Dec 2021
Next filing
08 Sep 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AVNS Common Stock Award $0 +11,241 +69% $0.000000 27,569 04 Mar 2022 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents time-based restricted share units awarded pursuant to the Issuer's 2021 Long Term Incentive Plan. The award will vest 1/3 on March 4, 2023, 1/3 on March 4, 2024 and 1/3 on March 4, 2025.
F2 Includes 4,728 shares which were reported on a Form 4 filed on May 6, 2019, but which were inadvertently omitted from subsequently filed Form 4s.